Retreatment With Immune Checkpoint Inhibitors in Solid Tumors: A Systematic Review

doi 10.37766/inplasy2020.4.0041
Full Text
Abstract

Available in full text

Date
Authors
Publisher

INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

Related search

Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis

Frontiers in Immunology
AllergyImmunology
2019English

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review

Cancers
Cancer ResearchOncology
2020English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

P3.04-18 the Efficacy and Safety of Solid Tumors Combination Therapy With Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Immune Checkpoint Inhibitors and Type 1 Diabetes Mellitus: A Case Report and Systematic Review

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Immune Checkpoint Inhibitor Combinations in Solid Tumors: Opportunities and Challenges

Immunotherapy
OncologyAllergyImmunology
2016English

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

Retreatment With Nivolumab in Patients With R/R Classical Hodgkin Lymphoma After Discontinuation of the Therapy With Immune Checkpoint Inhibitors

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors

Advances in Therapy
MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy